Search This Blog

Saturday, January 28, 2023

Pfizer Responds After Director Says Company Is Developing Ways To Mutate COVID-19

 by Zachary Stieber via The Epoch Times (emphasis ours),

Pfizer late Jan. 28 responded to comments from a director at the company about exploring ways to mutate COVID-19 as a method to “preemptively develop new vaccines.”

“In the ongoing development of the Pfizer-BioNTech COVID-19 vaccine, Pfizer has not conducted gain of function or directed evolution research,” Pfizer said in a lengthy written statement after days of ignoring queries from The Epoch Times and other outlets.

Pfizer did say that it has conducted research “where the original SARS-CoV-2 virus has been used to express the spike protein from new variants of concern.”

“This work is undertaken once a new variant of concern has been identified by public health authorities. This research provides a way for us to rapidly assess the ability of an existing vaccine to induce antibodies that neutralize a newly identified variant of concern. We then make this data available through peer reviewed scientific journals and use it as one of the steps to determine whether a vaccine update is required,” the company added.

Pfizer did say it has conducted experiments in a level 3 laboratory.

Pfizer said, in its work developing a treatment for COVID-19, it has “engineered” the COVID-19 virus “to enable the assessment of antiviral activity in cells.”

“In addition, in vitro resistance selection experiments are undertaken in cells incubated with SARS-CoV-2 and nirmatrelvir in our secure Biosafety level 3 (BSL3) laboratory to assess whether the main protease can mutate to yield resistant strains of the virus,” Pfizer said. “It is important to note that these studies are required by U.S. and global regulators for all antiviral products and are carried out by many companies and academic institutions in the U.S. and around the world.”

Pfizer produces a COVID-19 treatment called Paxlovid, or nirmatrelvir that is authorized in the United States and some other countries.

In its statement, Pfizer did not dispute that Dr. Jordon Walker, who told a Project Veritas journalist that Pfizer is exploring how to “mutate” the COVID-19 virus, was or is a Pfizer employee.

Professional profiles for Walker, which have since been taken down, listed him as a director of messenger RNA research at the company. Pfizer’s COVID-19 vaccine utilizes messenger RNA. The profiles also listed a Pfizer email address, and an email sent to that address did not bounce back. A receptionist at Pfizer on Thursday also told The Epoch Times that Walker had an internal company profile, but a different receptionist on Friday said there was no listing for the doctor, indicating he might have been terminated after the comments were made public.

Malone

Dr. Robert Malone, who helped develop the messenger RNA technology, said that the experiments Pfizer described met the definition of “gain of function.”

Pfizer is basically acknowledging that they are doing the same type of gain of function research that Boston University was caught doing, but they are denying that it is gain of function or directed evolution,” Malone wrote on Twitter.

Malone pointed to Pfizer’s comment about taking the original SARS-CoV-2 virus and using it “to express the spike protein from new variants of concern.”

Gain of function generally describes experiments that aim to increase functions of a virus such as transmissibility and virulence. Walker had said in his comments that the work he was describing was not gain of function, but “directed evolution.”

Researchers with Boston University revealed in 2022 that they had developed a strain of COVID-19 that killed 80 percent of mice infected with it.

The U.S. National Institutes of Health (NIH) is supposed to oversee risky research conducted in or funded by the United States but has faced criticism for only reviewing a handful of projects—none since 2019—under the oversight system.

The NIH funded gain of function experiments at the Wuhan laboratory situated near where the first COVID-19 cases were identified, and officials have promised to keep funding research in China.

Sen. Marco Rubio (R-Fla.) had written a letter to Pfizer CEO Albert Bourla referring to Walker’s remarks and questioning whether the company has or is planning to mutate the COVID-19 virus.

Walker’s comments “are alarming,” Rubio wrote in the Jan. 26 missive.

YouTube Takes Down Video

In a notice sent to Project Veritas, YouTube cited its medical misinformation policy, which bars “claims about COVID-19 vaccination that contradict expert consensus from local health authorities or the World Health Organization (WHO).”

It wasn’t clear which authorities specifically YouTube was relying upon to rebut the video.

YouTube, which is owned by Google, did not respond to a request for comment.

O’Keefe noted that the claims in the video were made by a Pfizer director.

Project Veritas was given a “strike,” which prevents the organization from taking actions like uploading new videos for one week. A second strike would block such actions for two weeks and a third strike in a 90-day period would result in a permanent removal of the group’s account, YouTube warned.

https://www.zerohedge.com/covid-19/pfizer-responds-after-director-says-company-developing-ways-mutate-covid-19

Delaware annuls 26 nurses' licenses amid degree scheme probe

 As state and federal investigations into a fraudulent nurse degree scheme continue, the Delaware Board of Nursing confirmed it has annulled the nursing licenses of 26 individuals, ABC affiliate WPVI reported Jan. 26.

The Justice Department on Jan. 25 said it uncovered a coordinated scheme to sell fraudulent diplomas and transcripts to aspiring nurses from three now-shuttered nursing schools in Florida. Individuals allegedly used the fake paperwork to fast-track the process for them to take the National Council Licensure Examination, even if they had not completed the necessary coursework to graduate or qualify for the test, federal authorities said. 

"All of us feel this is egregious," Pamela Zickafoose, MSN, RN, executive director of the Delaware Board of Nursing, told WPVI

It is unclear whether the 26 Delaware nurses who had their licenses annulled were actively working in direct patient care roles, and if they were, at what facilities. WPVI said the individuals may appeal the board's decision.

In total, 25 people face charges of wire fraud and wire fraud conspiracy for their alleged participation in the sale of more than 7,600 fraudulent diplomas and transcripts. If convicted, the defendants face up to 20 years in jail.

The National Council of State Boards of Nursing and its state regulatory bodies have also been working closely with state and federal authorities to identify and monitor individuals who allegedly purchased the fake nursing degrees. 

"Nursing regulatory bodies in affected states have been investigating individual cases and are taking appropriate action, in accordance with their state laws and due process, that includes loss of license," the national nursing board told Becker's Jan. 26. 

https://www.beckershospitalreview.com/nursing/delaware-annuls-26-nurses-licenses-amid-degree-scheme-probe.html

Rheinmetall moving towards order backlog of 30 billion euros - CEO

 

German arms maker Rheinmetall had a record year in 2022 and is approaching an order backlog of 30 billion euros, CEO Armin Papperger told Reuters in an interview.

"In 2022, we had a very good year, a record year," he said, saying that the fourth quarter would even beat good third quarter results.

"We are approaching an order backlog of 30 billion euros, and I expect to see an order backlog of 40 billion euros next year," said the CEO of the company, which sells a whole range of defence products but is probably most famous for supplying the 120mm gun of the Leopard 2 tank.

Papperger said he expected to see at least 15% to 20% growth in Rheinmetall's defence division over the coming years, with the civilian business likely to account for only 20% of sales in 2025.

On Tuesday, Papperger had nudged up the group's mid-term sales outlook in anticipation of a windfall from higher defence spending due to the war in Ukraine.

Rheinmetall expects sales to grow to 11 billion-12 billion euros ($12 billion -$13 billion) in 2025, he told German magazine Stern.

The projection is higher than the 10 billion-11 billion euro range Rheinmetall gave during its capital markets day in November. For 2022, the company expects 6.5 billion euros in sales.

https://www.marketscreener.com/quote/stock/RHEINMETALL-AG-436527/news/Rheinmetall-moving-towards-order-backlog-of-30-billion-euros-CEO-42835585/

Top U.S. Treasury official to warn Mideast countries over sanctions evasion

 

The U.S. Treasury Department's top sanctions official on a trip to the Middle East next week will warn countries and businesses that they could lose U.S. market access if they do business with entities subject to U.S. curbs as Washington cracks down on Russian attempts to evade sanctions imposed over its war in Ukraine.

Brian Nelson, undersecretary for terrorism and financial intelligence, will travel to Oman, the United Arab Emirates and Turkey from Jan. 29 to Feb. 3 and meet with government officials as well as businesses and financial institutions to reiterate that Washington will continue to aggressively enforce its sanctions, a Treasury spokesperson told Reuters.

"Individuals and institutions operating in permissive jurisdictions risk potentially losing access to U.S. markets on account of doing business with sanctioned entities or not conducting appropriate due diligence," the spokesperson said.

While in the region, Nelson will discuss Treasury's efforts to crack down on Russian efforts to evade sanctions and export controls imposed over its brutal war against Ukraine, Iran's destabilizing activity in the region, illicit finance risks undermining economic growth, and foreign investment. 

The trip marks the latest visit to Turkey by a senior Treasury official to discuss sanctions, following a string of warnings last year by Treasury and Commerce Department officials, as Washington ramped up pressure on Ankara to ensure enforcement of U.S. curbs on Russia.

STRAINED RELATIONS

Nelson's trip coincides with a period of strained ties between the United States and Turkey as the two NATO allies disagree over a host of issues.

Most recently, Turkey's refusal to green-light the NATO bids of Sweden and Finland has troubled Washington, while Ankara is frustrated that its request to buy F-16 fighter jets is increasingly linked to whether the two Nordic countries can join the alliance.

Nelson will visit Ankara, the Turkish capital, and financial hub Istanbul on Feb. 2-3. He will warn businesses and banks that they should avoid transactions related to potential dual-use technology transfers, which could ultimately be used by Russia's military, the spokesperson said.

Dual-use items can have both commercial and military applications.

Washington and its allies have imposed several rounds of sanctions targeting Moscow since the invasion, which has killed and wounded thousands and reduced Ukrainian cities to rubble.

Turkey has condemned Russia's invasion and sent armed drones to Ukraine. At the same time, it opposes Western sanctions on Russia and has close ties with both Moscow and Kyiv, its Black Sea neighbors.

    It has also ramped up trade and tourism with Russia. Some Turkish firms have purchased or sought to buy Russian assets from Western partners pulling back due to the sanctions, while others maintain large assets in the country.

    But Ankara has pledged that international sanctions will not be circumvented in Turkey.

    Washington is also concerned about evasion of U.S. sanctions on Iran.

The United States last month imposed sanctions on prominent Turkish businessman Sitki Ayan and his network of firms, accusing him of acting as a facilitator for oil sales and money laundering on behalf of Iran's Revolutionary Guard Corps.

While in the United Arab Emirates, Nelson will note the "poor sanctions compliance" in the country, the spokesperson said.

Washington has imposed a series of sanctions on United Arab Emirates-based companies over Iran-related sanctions evasion and on Thursday designated a UAE-based aviation firm over support to Russian mercenary company the Wagner Group, which is fighting in Ukraine.

https://www.marketscreener.com/news/latest/Exclusive-Top-U-S-Treasury-official-to-warn-Mideast-countries-over-sanctions-evasion--42833818/

Ukraine denies report it intends to get 24 jets from allies

 

Ukraine's air force on Saturday denied a newspaper report saying it intended to get 24 fighter jets from allies, saying talks about potential deliveries were still continuing, a domestic media outlet said.

Spain's El Pais newspaper, citing air force spokesperson Yuri Ihnat, said Ukraine initially wanted two squadrons of 12 planes each, preferably Boeing F-16 jets.

But in a statement provided to Ukraine's Babel outlet on Saturday, Ihnat said his comments to a media briefing on Friday had been misinterpreted.

"Ukraine is only at the stage of negotiations regarding aircraft. Aircraft models and their number are currently being determined," he said.

Ihnat told the Friday briefing that F-16s might be the best option for a multi-role fighter to replace the country's current fleet of ageing Soviet-era warplanes.

Later in the day, he told Ukrainian national television that allied nations did not like public speculation about jets, Interfax Ukraine news agency said.

"There were no statements. These things have a very negative impact. The information is very sensitive and partners do not like it when wishful thinking is presented," the agency cited him as saying.

Deputy White House national security adviser Jon Finer on Thursday said United States would be discussing the idea of supplying jets "very carefully" with Kyiv and its allies.

Germany's defence minister this week ruled out the idea of sending jets to Ukraine.

https://www.marketscreener.com/quote/stock/BOEING-4816/news/Ukraine-denies-report-it-intends-to-get-24-jets-from-allies-media-42835601/

Bayer investor calls for swift replacement of CEO: newspaper

 

Bayer investor Deka has called for CEO Werner Baumann to be replaced ahead of his scheduled departure, adding to mounting pressure on the German drugmaker.

"Bayer needs a new strategic positioning, which cannot be credibly accomplished under Werner Baumann," Ingo Speich, head of sustainability and corporate governance at Deka, told the Frankfurter Allgemeine Sonntagszeitung (FAS) newspaper in remarks published on Saturday.

The mutual funds firm is among Bayer's 20 largest shareholders.

"There is a window of opportunity for Chairman Norbert Winkeljohann to act before the annual general meeting at the end of April. He has to seize that opportunity, otherwise the pressure on him will increase as well," Speich added.

He said a successor would have to come from outside the company.

"Generally speaking we are always open to a constructive dialogue with our stakeholders," a Bayer spokesperson said, declining to comment specifically on the interview.

Despite recent improvements in the company's agriculture business and drug development prospects, Bayer shares have been weighed down by litigation over glyphosate-based herbicide Roundup and over environmental pollution related to chemicals known as PCBs.

The legal claims are legacy issues from its takeover of Monsanto for more than $60 billion in 2018.

Baumann, who engineered the troubled Monsanto deal, was given a new contract in 2020 that runs until 2024 and said at the time he would leave the company when that term expires.

A week ago mutual funds group Union Investment criticised Bayer's chair for a lack of engagement, such as exploring a spin-off of the company's consumer health division.

Bayer is also facing demands from activist investor Bluebell Capital Partners to break up the company, including selling off its consumer health unit and later a separation of its pharmaceuticals and agricultural businesses.

Another activist investment fund, hedge fund veteran Jeffrey Ubben's Inclusive Capital Partners, said this month it had also acquired a stake in Bayer.

https://www.marketscreener.com/quote/stock/BAYER-AG-436063/news/Bayer-investor-calls-for-swift-replacement-of-CEO-newspaper-42834135/

Russia Readies Robotic Response To 'Secret Armor-Less' Abrams Tanks In Donbas

 Western media outlets flooded the airways with hope for Ukraine this week as the US prepares to send 31 main battle tanks to the wartorn country in Eastern Europe to counter Russian aggression ahead of spring. What wasn't highly publicized is that these M1 Abrams are a modified version and will be stripped of "secret" uranium armor. 

Following the news of NATO-made tanks set to flood Ukraine, the former head of Russia's space agency Dmitry Rogozin told the Russian newspaper Pravda that "Marker," a new robo-tank, will be able to 'destroy Western tanks, including American Abrams and German Leopards.' 

Rogozin explained the robot tank automatically recognizes and attacks Ukrainian equipment, including NATO tanks, all because of its artificial intelligence system and machine learning technology. 

"The combat version of the Marker robot has an electronic catalog in the control system that contains images of targets both in the visible and in the infrared range," he said.

The director of the Air Defense Museum, retired colonel Yuri Knutov, told Lenta.Ru, a Russian newspaper, "the robot can thus identify NATO-made tanks" and will be "armed with a machine gun and an anti-tank missile with a range of up to about six kilometers." 

On Wednesday, Rogozin wrote on his Telegram Channel:

"The shock version of the Marker robot, which will enter the special operation zone [Donbas] in February, will be able to automatically detect and hit Ukrainian equipment, including American Abrams tanks and German Leopard tanks."

One major issue Ukanian forces might encounter with the M1 Abrams, besides weight and a gas-guzzling turbine engine, is that these are older versions and stripped of "secret" uranium armor. This could mean these tanks are vulnerable. 

According to Politico, the export of Abrams with classified armor is forbidden as there are fears the tanks, if captured, could be reverse-engineered. 

The lingering question is if these stripped-down Abrams can withstand an anti-tank rocket. 

Or better yet, one from a Russian robot tank. 

https://www.zerohedge.com/military/russia-readies-robotic-response-secret-armor-less-abrams-tanks-dobas